Our Story

Noven – 1987 to Today

Noven's history began in 1987 in Miami, Florida, with the mission to develop differentiated prescription transdermal drug delivery systems (patches) to benefit patients across a range of therapeutic conditions. Today, Noven is the US platform for Hisamitsu, the world's largest patch manufacturer, with fully integrated R&D, clinical, manufacturing, and sales functions offering prescription products in the areas of women's health and mental health.

History

October-2012
Minivelle®, world's smallest estrogen patch, approved by FDA
February-2011
Noven's Northeast operations consolidated in Empire State Building co-headquarters
February-2010
Noven reacquires Daytrana® (methylphenidate transdermal system) from Shire
February-2010
Hisamitsu Carlsbad facility integrated with Noven operations
February-2009
Noven acquired by Hisamitsu Pharmaceuticals; public company status concludes
February-2007
Noven acquires JDS Pharmaceuticals, expanding its portfolio and sales capabilities
February-2006
Shire and Noven launch Daytrana®
February-2003
Shire licenses Noven's Daytrana® patch for ADHD
February-1999
Launch of Vivelle-Dot® (estradiol transdermal system), the world's smallest estrogen patch at the time
February-1998
Launch of CombiPatch® (estradiol/norethindrone acetate transdermal system), the first combination (two-drug) patch

Fast Facts

Core Business:
Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.

Year of Incorporation:
1987

Employees:
Over 300

Board Member & Chief Executive Officer:
Takeshi Masumoto

Media, General Business
& Other Inquiries:
CorporateAffairs@noven.com

Partnering and Other Business Development Opportunities
Tel: 551-233-2700
BusDev@noven.com

Employment Inquiries:
Marilyn Reynaldo
Associate Director –
Talent Acquisition
mreynaldo@noven.com

Community Support:
Corporate Social Responsibility

Affiliated Companies:
Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. – bringing the benefits of patch therapy to patients around the world.

Noven's commercialized products are marketed and sold through Noven Therapeutics, LLC.

Grove Pharmaceuticals is the generic division of Noven Therapeutics, LLC.